


Healthcare Industry NewsFeed
HSMN NewsFeed - 9 Apr 2021
NeuX Technologies Announces Dr. John Pecora as Vice President of Business Development
NeuX Technologies Announces Dr. John Pecora as Vice President of Business Development
HSMN NewsFeed - 7 Apr 2021
FDA Approves Bausch & Lomb ClearVisc(TM) Dispersive Ophthalmic Viscosurgical Device
FDA Approves Bausch & Lomb ClearVisc(TM) Dispersive Ophthalmic Viscosurgical Device
HSMN NewsFeed - 6 Apr 2021
Seelos Therapeutics Announces a Strategic Device Partnership with AptarGroup, Inc.
Seelos Therapeutics Announces a Strategic Device Partnership with AptarGroup, Inc.
HSMN NewsFeed - 5 Apr 2021
NLS Pharmaceutics Appoints Silvia Panigone, Ph.D. As Chief Operating Officer
NLS Pharmaceutics Appoints Silvia Panigone, Ph.D. As Chief Operating Officer
HSMN NewsFeed - 5 Apr 2021
IceCure Medical Granted FDA Breakthrough Device Designation for ProSense(R) Cryoablation System
IceCure Medical Granted FDA Breakthrough Device Designation for ProSense(R) Cryoablation System
HSMN NewsFeed - 5 Apr 2021
Ionis initiates Phase 3 trial of novel antisense medicine to treat leading cause of juvenile-onset ALS
Ionis initiates Phase 3 trial of novel antisense medicine to treat leading cause of juvenile-onset ALS
HSMN NewsFeed - 31 Mar 2021
Zimmer Biomet Announces Key Updates to Company's Executive Leadership Team
Zimmer Biomet Announces Key Updates to Company's Executive Leadership Team
HSMN NewsFeed - 30 Mar 2021
Expansion of Raystation Treatment Planning System at The Inova Schar Cancer Institute
Expansion of Raystation Treatment Planning System at The Inova Schar Cancer Institute
HSMN NewsFeed - 30 Mar 2021
PTC Therapeutics Announces the European Approval of Evrysdi(TM) for the Treatment of Spinal Muscular Atrophy
PTC Therapeutics Announces the European Approval of Evrysdi(TM) for the Treatment of Spinal Muscular Atrophy
HSMN NewsFeed - 29 Mar 2021
Phoenix Molecular Designs Appoints Biotech Powerhouse, Michael Varney, Ph.D., to its Advisory Board
Phoenix Molecular Designs Appoints Biotech Powerhouse, Michael Varney, Ph.D., to its Advisory Board
